Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 1119 results for "aurobindo"

TVS Motors, Aurobindo Pharma among 7 stocks that remained in focus today
Financial Express

TVS Motors, Aurobindo Pharma among 7 stocks that remained in f...

TVS Motor shares closed 9.66 per cent down at Rs 287.90 despite posting 30.09 per cent rise in its net profit figures at Rs 117.76 crore for the quarter ended March 2016. It has posted a net profit of Rs 90.52 crore in the same quarter last year. Financial Express, 2 hours ago

FDA approves Aurobindo's epilepsy drug

Singapore: The US Food & Drug Administration (USFDA) has granted approval for Aurobindo Pharma's epilepsy prevention drug Lacosamide. Aurobindo Pharma is India's leading drugmaker. Epilepsy is the fourth common neurological disorder that affects ...
 Bio Spectrum Asia2 hours ago Aurobindo Pharma surges as foreign brokerage initiates coverage  Business Standard4 hours ago Aurobindo Pharma gains on USFDA approval for epilepsy drug  Sify7 hours ago India : AUROBINDO PHARMA gets terminal USFDA affirmation for Esomeprazole Magnesium Delayed-release Capsules [TendersInfo (India)]  Pharmacy Choice3 days ago
Money Today

Today's picks: 3 May 2016

Nifty, Bank Nifty, HCL Technologies, Aurobindo Pharma & ITC Devangshu Datta May 3, 2016 Last Updated at 06:00 IST Nifty Current: 7,806 (futures: 7,840) Target: NA Stop-long positions at 7,770. Stop-short positions at 7,910. Big moves could go till 7,725, ...
 Business Standard13 hours ago New entrants see mixed trend on Nifty 50 index inclusion  Times of India1 month ago Eicher, Aurobindo, Bharti Infratel Make Weak Debut On Nifty  NDTV1 month ago New entrants make weak debut on Nifty 50 index  Money Today1 month ago

Sell Coal India, YES Bank; buy Aurobindo Pharma: Ashwani Gujral

Ashwani Gujral of recommends selling Coal India and YES Bank and advises buying Aurobindo Pharma.
 Money Control4 hours ago Buy SBI, Aurobindo Pharma; sell Jubilant Foodworks: Gujral  Money Control1 week ago Buy YES Bank, ACC, Aurobindo Pharma: Ashwani Gujral  Money Control3 weeks ago Sell BEML, Federal Bank, Colgate; buy Auro Pharma: Ashish Kyal  Money Control4 weeks ago

Aurobindo Pharma trades with traction on the bourses

SENSEX 25290.40 146.57 0.58% NIFTY 7762.05 43.85 0.56% Industry: Medical/Healthcare Company Aurobindo Pharma Ltd Aurobindo Pharma is currently trading at Rs. 801.50, up by 31.80 points or 4.13 % from its previous closing of ...
 Finalaya.com5 hours ago

Credit Suisse, Goldman Sachs upgrades lift Aurobindo scrip

MUMBAI: Shares of Aurobindo Pharma jumped 4.7% to Rs 806 as Credit Suisse and Goldman Sachs have initiated coverage on the stock and given positive commentary on the company's growth prospects. Credit Suisse has started coverage on Aurobindo ...
 Economic Times5 hours ago

Buy Aurobindo Pharma with a target at Rs 835: Mitesh Thacker

Mitesh Thacker of recommends a buy rating on Aurobindo Pharma with a target price of Rs 835 and a strict stop loss placed at Rs 786. The stock has slipped 8.35 per cent so far in the calendar year 2016. The stock is looking bullish ...
 Economic Times6 hours ago Sell Aurobindo Pharma with a target of Rs 710: Sameet Chavan  Economic Times3 weeks ago Aurobindo Pharma may test Rs 780: Shahina Mukadam  Money Control1 month ago Buy Aurobindo Pharma; target of Rs 905: Emkay  Money Control2 months ago

Buy Aurobindo Pharma, Rolta India, Bharti Airtel: Ashwani Gujral

Ashwani Gujral of recommends buying Aurobindo Pharma, Rolta India and Bharti Airtel.
 Money Control7 hours ago Buy SBI, Jet Airways, Aurobindo Pharma: Ashwani Gujral  Money Control4 weeks ago Buy Bata India, Gujarat Pipavav, Aurobindo Pharma: Gujral  Money Control4 weeks ago Buy BPCL, Adani Port, Kotak Mahindra Bank: Gujral  Money Control2 months ago
Business Line

Stocks in focus: Tata Motors, Hero MotoCorp, HDFC, Aurobindo

Shares of Tata Motors ended higher by over 0.5 per cent Rs 409.50 after gaining over 3 per cent earlier in the day. Led by monthly sales volume data, shares of the company climbed 3.57 per cent to Rs 421.85 on the BSE. On the NSE, it rose 3.5 per cent to Rs ...
 Business Line8 hours ago Tata Motors DVR, 3 other companies gain on Nifty inclusion  Money Today2 months ago Tata Motors DVR, three other cos gain on Nifty inclusion  Business Line2 months ago Tata Motors DVR, 3 other cos gain on Nifty inclusion  The Financial Chronicle2 months ago

Aurobindo Pharma hits three-month high

Aurobindo Pharma has surged 5% to Rs 809, its highest level since February 2, this year on the BSE. The stock has gained over 6% in the past two trading sessions after the company said it has received final approval from the US Food & Drug ...
 Smart Investor7 hours ago Analysts see correction in Aurobindo as an entry point  Business Standard2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - aurobindo
Get updated on latest news & your favorite topics right in your inbox!
More     Less